期刊文献+

环氧化酶-2在人肺癌组织中的表达及意义 被引量:1

The expression of cyclooxygenase-2 and its significance in human lung cancer tissue.
暂未订购
导出
摘要 目的近期发现环氧化酶-2(cyclooxygenase-2,COX-2)在肺癌组织中有高表达且对该疾病的预后有重要影响。为阐明这一问题,对COX-2在人肺癌组织中的表达及作用进行了研究。方法运用组织芯片技术制成126例肺癌组织芯片,采用免疫组化方法对标本中COX-2的表达进行检测,并对COX-2的表达情况与疾病生物学特点、患者生存时间等关系进行了回顾性队列研究。结果COX-2阳性表达86例(68.25%)。COX-2在肿瘤中的表达与肿瘤T分期、N分期及疾病临床分期等肿瘤部分生物学特性有相关性(P<0.05)。结论COX-2在人肺癌组织中有高表达,其表达能作为患者生存时间预测的单因素影响因子,成为外科手术切除后的肺癌病例预后较差的标志。 Objective Elevated expression of cyclooxygenase-2 (COX-2) has been found to be a feature of lung cancer recently. To clarify these issues , we studied the expression of COX-2 in tissues of patients with lung cancer .Methods Expression of COX-2 in specimens of 126 lung cancer patients were evaluated by tissue chip and immunohistochemical methods. The relationships between COX-2 expression,survival time and the biology behavior of lung cancer were analyzed by retrospective cohort study. Results Expression of COX-2 was positive in 86 cases (68.25%). The correlation between COX-2 expression and some biology behaviors of lung cancer(T stage、N stage and clinical stage)was significant in statistics(P<0.05). Conclusion Expression of COX-2 is detected in lung cancer tissue. It is suggested to be an independent predictor of survival in survival analysis and it is significant poor prognostic factor in the surgically resected lung cancer.
出处 《现代肿瘤医学》 CAS 2005年第3期345-348,共4页 Journal of Modern Oncology
关键词 肺癌 环氧化酶 生存分析 lung cancer cyclooxygenase-2 (COX-2) survival analysis
  • 相关文献

参考文献2

二级参考文献37

  • 1[1]Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer,2000,89(12):2637-26345.
  • 2[2]Wolff H, Saukkonen K, Anttila S, et al. Expression of cyclooxygenase-2 in human lung carcinoma.Cancer Res,1998,58(22):4997-5001.
  • 3[3]Ochiai M, Oguri T, Isobe T, et al. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res,1999,90(12):1338-1343.
  • 4[4]Hasturk S, Kemp B, Kalapurakal SK, et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer,2002,94(4):1023-1031.
  • 5[5]Wardlaw SA, March TH, Belinsky SA. Cyclooxygenase-2 expression is abundant in alveolar type Ⅱ cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis,2000,21(7):1371-1377.
  • 6[6]Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res,1998,58(17):3761-3764.
  • 7[7]Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell,1995,83(3):493-501.
  • 8[8]O'Byrne KJ, Dalgleish AG, Browning MJ, et al. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer,2000,36(2):151-169.
  • 9[9]Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res,2000,6(1):135-138.
  • 10[10]Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung can-cer. Clin Cancer Res,2001,7(4):861-867.

共引文献17

同被引文献11

  • 1刘莹,崔涛,朱祖安,费素娟,杨雪梅.NF-κB、COX-2在结肠癌及癌前病变中的表达及其临床意义[J].徐州医学院学报,2007,27(1):15-19. 被引量:10
  • 2BAGCHI D, BAGCHI M, STOHS S J, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention[J]. Toxicology, 2000, 148(2 - 3) :187 - 197.
  • 3SCHMIDT B M, ERDMAN J W J, LILA M A. Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines[J]. Cancer Lett, 2006, 231(2) :240 - 246.
  • 4MITTAL A, ELMETS C A, KATIYAR S K. Dietary feeding of proanthocyanidins from seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation [ J ]. Carcinogenesis, 2003, 24(8) : 1379 - 1388.
  • 5PELLETIER J P, MARTEL-PELLETIER J, ABRAMSON S B. Osteorthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [ J ]. Arthritis Rheum, 2001, 44 ( 6 ) : 1237 - 1247.
  • 6TAKAHASHI T, KOZAKI K, YATABE Y, et al. Increased expression of COX-2 in the development of human lung cancers[J]. J Environ Pathol Toxicol Oncol, 2002, 21 (2) .- 177 - 181.
  • 7SPIELMAN L, WINGER D, HO L, et al. Induction of the complement component ClqB in brain of transgenie mice with neuronal overexpression of human cyclooxygenase-2 [ J ]. Acta Neuropathol, 2002, 103 ( 2 ) : 157- 162.
  • 8MITCHELL J A, SAUNDERS M, BARNES P J, et al. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappa B)activation: role of arachidonic acid[J]. Mol Pharmacol, 1997, 51(6) :907 - 912.
  • 9MESTRE J R, RIVADENEIRA D E, MACKRELL P J, et al. Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in maerophages [J]. FEBS Lett, 2001, 496 (2 - 3) : 147 - 151.
  • 10BENITAH S A, VALERON P F, LACAL J C. Rock and nuclear factor-kappaB -dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences [ J ]. Mol Biol Cell,2003, 14 (7) :3041 - 3054.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部